WELLINGTON MANAGEMENT GROUP LLP - SINOVAC BIOTECH LTD ownership

SINOVAC BIOTECH LTD's ticker is SVA and the CUSIP is P8696W104. A total of 38 filers reported holding SINOVAC BIOTECH LTD in Q2 2017. The put-call ratio across all filers is - and the average weighting 2.3%.

Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of SINOVAC BIOTECH LTD
ValueSharesWeighting
Q4 2017$544,000
+11.9%
69,0980.0%0.00%
Q3 2017$486,000
+604.3%
69,098
+574.1%
0.00%
Q2 2017$69,000
+16.9%
10,2500.0%0.00%
Q1 2017$59,000
-99.8%
10,250
-99.8%
0.00%
-100.0%
Q4 2016$32,575,000
+2.7%
5,521,262
+2.7%
0.01%0.0%
Q3 2016$31,711,000
+2.0%
5,374,659
+2.6%
0.01%0.0%
Q2 2016$31,074,000
-7.4%
5,240,212
-0.2%
0.01%
-11.1%
Q1 2016$33,562,000
+12.2%
5,252,235
+0.4%
0.01%
+12.5%
Q4 2015$29,913,000
+28.5%
5,229,421
+14.1%
0.01%
+33.3%
Q3 2015$23,282,000
+9.0%
4,583,027
+12.6%
0.01%0.0%
Q2 2015$21,359,000
-5.8%
4,068,406
-11.0%
0.01%0.0%
Q1 2015$22,669,000
-1.2%
4,570,512
+4.1%
0.01%0.0%
Q4 2014$22,954,000
+12.1%
4,389,060
+3.1%
0.01%0.0%
Q3 2014$20,485,000
-7.9%
4,258,749
+7.9%
0.01%0.0%
Q2 2014$22,253,000
-39.6%
3,945,465
-23.0%
0.01%
-40.0%
Q1 2014$36,871,000
+54.9%
5,120,943
+31.7%
0.01%
+42.9%
Q4 2013$23,797,000
+37.1%
3,888,473
+34.0%
0.01%
+40.0%
Q3 2013$17,352,000
+58.0%
2,901,733
+3.9%
0.01%
+25.0%
Q2 2013$10,981,0002,794,0710.00%
Other shareholders
SINOVAC BIOTECH LTD shareholders Q2 2017
NameSharesValueWeighting ↓
Orbimed Advisors 2,718,735$340,500,0006.32%
Vivo Capital, LLC 5,900,000$38,173,0004.21%
Neumann Advisory Hong Kong Ltd 315,586$2,0420.72%
Yorktown Management & Research Co Inc 74,893$485,0000.63%
Skandinaviska Enskilda Banken AB (publ) 40,000$259,0000.00%
Renaissance Technologies 2,375,841$1,537,0000.00%
WELLS FARGO & COMPANY/MN 1,687$11,0000.00%
NORTHERN TRUST CORP 13,787$55,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 412$27,0000.00%
View complete list of SINOVAC BIOTECH LTD shareholders